Ionis Pharmaceuticals, Inc.

NasdaqGS:IONS Stock Report

Market Cap: US$5.4b

Ionis Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:IONS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 May 24SellUS$256,277Joseph KleinIndividual6,000US$42.98
16 Feb 24SellUS$17,219Brett MoniaIndividual387US$44.49
02 Feb 24SellUS$91,752C. BennettIndividual1,853US$49.52
02 Feb 24SellUS$98,135Richard GearyIndividual1,961US$50.04
02 Feb 24SellUS$105,272Elizabeth HougenIndividual2,125US$49.54
02 Feb 24SellUS$97,410Patrick O'NeilIndividual1,961US$49.67
02 Feb 24SellUS$105,404Onaiza Cadoret-ManierIndividual2,125US$49.60
02 Feb 24SellUS$1,160,303Brett MoniaIndividual23,501US$49.37
02 Feb 24SellUS$102,701Eugene SchneiderIndividual2,071US$49.59
02 Feb 24SellUS$654,709Eric SwayzeIndividual12,680US$52.00
25 Jan 24SellUS$333,788Patrick O'NeilIndividual6,450US$51.75
25 Jan 24SellUS$118,249Brett MoniaIndividual2,285US$51.75

Insider Trading Volume

Insider Buying: IONS insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of IONS?
Owner TypeNumber of SharesOwnership Percentage
Private Companies5,9670.00409%
State or Government63,5820.0436%
General Public159,3830.109%
Individual Insiders1,171,0690.803%
Institutions144,445,85199%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 78.18% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15%
FMR LLC
21,862,735US$815.7m1.59%0.05%
11.6%
T. Rowe Price Group, Inc.
16,839,315US$628.3m-3.54%0.06%
9.21%
The Vanguard Group, Inc.
13,430,456US$501.1m-5.44%0.01%
6.7%
BlackRock, Inc.
9,771,891US$364.6m7.89%0.01%
5.69%
Bellevue Asset Management AG
8,299,514US$309.7m-4.76%3.71%
3.91%
Wellington Management Group LLP
5,695,699US$212.5m23.4%0.03%
3.06%
ClearBridge Investments, LLC
4,466,191US$166.6m-5.13%0.13%
2.85%
State Street Global Advisors, Inc.
4,155,664US$155.0m3.66%0.01%
2.56%
Pictet Asset Management Limited
3,739,757US$139.5m6.29%0.1%
2.37%
Tweedy, Browne Company LLC
3,454,676US$128.9m0%1.71%
2.19%
Macquarie Investment Management Business Trust
3,200,578US$119.4m3.64%0.14%
1.67%
BVF Partners L.P.
2,428,613US$90.6m0%2.72%
1.62%
Geode Capital Management, LLC
2,364,256US$88.2m3.88%0.01%
1.38%
OrbiMed Advisors LLC
2,013,033US$75.1m-2.51%1.07%
0.96%
ARK Investment Management LLC
1,399,852US$52.2m-26.5%0.4%
0.94%
Deep Track Capital, LP
1,373,475US$51.2m9.96%1.62%
0.89%
Charles Schwab Investment Management, Inc.
1,301,368US$48.6m2.04%0.01%
0.88%
Point72 Asset Management, L.P.
1,282,068US$47.8m6.99%0.1%
0.8%
Norges Bank Investment Management
1,171,936US$43.7m0%no data
0.74%
Two Sigma Investments, LP
1,083,879US$40.4m35.2%0.11%
0.71%
Two Sigma Advisers, LP
1,040,111US$38.8m33.9%0.09%
0.69%
Adage Capital Management, L.P.
1,000,000US$37.3m-27.8%0.07%
0.63%
Candriam
911,897US$34.0m45%0.1%
0.62%
TD Asset Management, Inc.
898,362US$33.5m-6.11%0.03%
0.58%
Capital Research and Management Company
839,463US$31.3m0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.